The last 1/4ly did state “research and development expenditures in the December quarter relate to three clinical trials which have completed expensive clinical stage. Hence, future expenditures will be lower.” We don’t know however the payment terms for CRO and what % was still to be completed end December. However R&D expense in December 1/4ly was historically very high.
- Forums
- ASX - By Stock
- $30 Billion Deal
The last 1/4ly did state “research and development expenditures...
-
- There are more pages in this discussion • 393 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.7¢ |
Change
-0.003(10.0%) |
Mkt cap ! $24.36M |
Open | High | Low | Value | Volume |
2.9¢ | 2.9¢ | 2.6¢ | $49.52K | 1.782M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 192359 | 2.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.9¢ | 27000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 192359 | 0.027 |
3 | 199230 | 0.026 |
6 | 700000 | 0.025 |
2 | 3483333 | 0.024 |
4 | 825000 | 0.022 |
Price($) | Vol. | No. |
---|---|---|
0.029 | 27000 | 2 |
0.030 | 138528 | 6 |
0.031 | 280868 | 5 |
0.032 | 513492 | 2 |
0.033 | 350000 | 2 |
Last trade - 16.10pm 12/08/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |